Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children.

Keck JW, Wenger JD, Bruden DL, Rudolph KM, Hurlburt DA, Hennessy TW, Bruce MG.

Vaccine. 2014 Nov 12;32(48):6478-84. doi: 10.1016/j.vaccine.2014.09.037. Epub 2014 Sep 28.

PMID:
25269095
2.

Migration of persons between households in rural Alaska: considerations for study design.

Bruden D, Bruce MG, Wenger JD, Hurlburt DA, Bulkow LR, Hennessy TW.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21229. eCollection 2013.

3.

Poliovirus vaccination options for achieving eradication and securing the endgame.

Estívariz CF, Pallansch MA, Anand A, Wassilak SG, Sutter RW, Wenger JD, Orenstein WA.

Curr Opin Virol. 2013 Jun;3(3):309-15. doi: 10.1016/j.coviro.2013.05.007. Epub 2013 Jun 10. Review.

PMID:
23759252
4.

Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.

Bruce MG, Zulz T, DeByle C, Singleton R, Hurlburt D, Bruden D, Rudolph K, Hennessy T, Klejka J, Wenger JD.

Emerg Infect Dis. 2013 Jun;19(6):932-7. doi: 10.3201/eid1906.121805.

5.

Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska.

Zulz T, Wenger JD, Rudolph K, Robinson DA, Rakov AV, Bruden D, Singleton RJ, Bruce MG, Hennessy TW.

J Clin Microbiol. 2013 May;51(5):1402-7. doi: 10.1128/JCM.02880-12. Epub 2013 Feb 13.

6.

Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population.

Singleton RJ, Holman RC, Folkema AM, Wenger JD, Steiner CA, Redd JT.

J Pediatr. 2012 Aug;161(2):296-302.e2. doi: 10.1016/j.jpeds.2012.02.004. Epub 2012 Mar 19.

PMID:
22437150
7.

Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs.

Jackson ML, Rose CE, Cohn A, Coronado F, Clark TA, Wenger JD, Bulkow L, Bruce MG, Messonnier NE, Hennessy TW.

Emerg Infect Dis. 2012 Jan;18(1):13-20. doi: 10.3201/eid1801.110336.

8.

Poliomyelitis-related case-fatality ratio in India, 2002-2006.

Doshi SJ, Sandhu HS, Venczel LV, Hymbaugh KJ, Deshpande JM, Pallansch MA, Bahl S, Wenger JD, Cochi SL.

Clin Infect Dis. 2011 Jul 1;53(1):13-9. doi: 10.1093/cid/cir332.

PMID:
21653297
9.

2009 Pandemic influenza A H1N1 in Alaska: temporal and geographic characteristics of spread and increased risk of hospitalization among Alaska Native and Asian/Pacific Islander people.

Wenger JD, Castrodale LJ, Bruden DL, Keck JW, Zulz T, Bruce MG, Fearey DA, McLaughlin J, Hurlburt D, Hummel KB, Kitka S, Bentley S, Thomas TK, Singleton R, Redd JT, Layne L, Cheek JE, Hennessy TW.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S189-97. doi: 10.1093/cid/ciq037.

PMID:
21342894
10.

Acute limb ischemia after a proximal humeral epiphyseal fracture: intraoperative findings of an illustrative vascular lesion.

Wenger JD, Olsson CJ.

J Shoulder Elbow Surg. 2011 Apr;20(3):e1-3. doi: 10.1016/j.jse.2010.10.025. Epub 2011 Jan 13. No abstract available.

PMID:
21232985
11.

Invasive pneumococcal disease in Alaskan children: impact of the seven-valent pneumococcal conjugate vaccine and the role of water supply.

Wenger JD, Zulz T, Bruden D, Singleton R, Bruce MG, Bulkow L, Parks D, Rudolph K, Hurlburt D, Ritter T, Klejka J, Hennessy T.

Pediatr Infect Dis J. 2010 Mar;29(3):251-6. doi: 10.1097/INF.0b013e3181bdbed5.

PMID:
19952861
12.

Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population.

Byrd KK, Holman RC, Bruce MG, Hennessy TW, Wenger JD, Bruden DL, Haberling DL, Steiner C, Cheek JE.

Clin Infect Dis. 2009 Oct 1;49(7):1009-15. doi: 10.1086/605560.

PMID:
19725783
13.

Author's reply.

Wenger JD, Gupta D.

Indian J Pediatr. 2005 Mar;72(3):267-268. doi: 10.1007/BF02859274. No abstract available.

PMID:
28378177
14.

Rapid assessment tool for Haemophilus influenzae type b disease in developing countries.

Feikin DR, Nelson CB, Watt JP, Mohsni E, Wenger JD, Levine OS.

Emerg Infect Dis. 2004 Jul;10(7):1270-6.

15.

Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria: a prospective, population-based surveillance study.

Kojouharova M, Gatcheva N, Setchanova L, Robertson SE, Wenger JD.

Bull World Health Organ. 2002;80(9):690-5.

16.

Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.

Leake JA, Kone ML, Yada AA, Barry LF, Traore G, Ware A, Coulibaly T, Berthe A, Mambu Ma Disu H, Rosenstein NE, Plikaytis BD, Esteves K, Kawamata J, Wenger JD, Heymann DL, Perkins BA.

Bull World Health Organ. 2002;80(5):342-9.

17.

Defining the burden of Hib disease in India.

Levine OS, Wenger JD.

Indian Pediatr. 2002 Jan;39(1):5-11. No abstract available.

PMID:
11805348
18.

Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries.

Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T.

Vaccine. 1999 Nov 12;18(7-8):736-42.

PMID:
10547434
20.

Serogroup B meningococcal disease: new outbreaks, new strategies.

Wenger JD.

JAMA. 1999 Apr 28;281(16):1541-3. No abstract available.

PMID:
10227326
21.
23.

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.

Perkins BA, Jonsdottir K, Briem H, Griffiths E, Plikaytis BD, Hoiby EA, Rosenqvist E, Holst J, Nokleby H, Sotolongo F, Sierra G, Campa HC, Carlone GM, Williams D, Dykes J, Kapczynski D, Tikhomirov E, Wenger JD, Broome CV.

J Infect Dis. 1998 Mar;177(3):683-91.

PMID:
9498448
24.

Efficacy of meningococcal vaccine and barriers to vaccination.

Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, Perkins BA.

JAMA. 1998 Feb 11;279(6):435-9.

PMID:
9466635
25.

Bacterial meningitis in the United States in 1995. Active Surveillance Team.

Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA.

N Engl J Med. 1997 Oct 2;337(14):970-6.

26.

Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease.

Raymond NJ, Reeves M, Ajello G, Baughman W, Gheesling LL, Carlone GM, Wenger JD, Stephens DS.

J Infect Dis. 1997 Nov;176(5):1277-84.

PMID:
9359729
27.

Tobacco smoke as a risk factor for meningococcal disease.

Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR, Bell TA, Fleming DW, Wenger JD, Perkins BA.

Pediatr Infect Dis J. 1997 Oct;16(10):979-83.

PMID:
9380476
28.

Recommendations for the use of Haemophilus influenzae type b vaccines among children in the United States.

Bisgard KM, Wenger JD.

Pediatr Ann. 1997 Jun;26(6):361-5. Review. No abstract available.

PMID:
9188127
29.

School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis.

Zangwill KM, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW, Wenger JD.

JAMA. 1997 Feb 5;277(5):389-95.

PMID:
9010171
30.

Capsule switching of Neisseria meningitidis.

Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, Wenger JD, Stephens DS.

Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):271-6.

31.
32.

Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease.

Jackson LA, Alexander ER, DeBolt CA, Swenson PD, Boase J, McDowell MG, Reeves MW, Wenger JD.

Pediatr Infect Dis J. 1996 Nov;15(11):992-8.

PMID:
8933547
33.

Molecular epidemiology of diphtheria in Russia, 1985-1994.

Popovic T, Kombarova SY, Reeves MW, Nakao H, Mazurova IK, Wharton M, Wachsmuth IK, Wenger JD.

J Infect Dis. 1996 Nov;174(5):1064-72.

PMID:
8896510
34.

Meningococcal disease in Los Angeles County, California, and among men in the county jails.

Tappero JW, Reporter R, Wenger JD, Ward BA, Reeves MW, Missbach TS, Plikaytis BD, Mascola L, Schuchat A.

N Engl J Med. 1996 Sep 19;335(12):833-40.

35.
36.

Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study.

Mohle-Boetani JC, Koehler JE, Berger TG, LeBoit PE, Kemper CA, Reingold AL, Plikaytis BD, Wenger JD, Tappero JW.

Clin Infect Dis. 1996 May;22(5):794-800.

PMID:
8722933
37.

Outbreak of serogroup C meningococcal disease associated with campus bar patronage.

Imrey PB, Jackson LA, Ludwinski PH, England AC 3rd, Fella GA, Fox BC, Isdale LB, Reeves MW, Wenger JD.

Am J Epidemiol. 1996 Mar 15;143(6):624-30.

PMID:
8610679
38.

Utility of emergency, telephone-based national surveillance for Hantavirus pulmonary syndrome. Hantavirus Task Force.

Tappero JW, Khan AS, Pinner RW, Wenger JD, Graber JM, Armstrong LR, Holman RC, Ksiazek TG, Khabbaz RF.

JAMA. 1996 Feb 7;275(5):398-400.

PMID:
8569020
39.

Sporadic meningococcal disease in adults: results of a 5-year population-based study.

Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM.

Ann Intern Med. 1995 Dec 15;123(12):937-40.

PMID:
7486489
40.

Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak.

Imrey PB, Jackson LA, Ludwinski PH, England AC 3rd, Fella GA, Fox BC, Isdale LB, Reeves MW, Wenger JD.

J Clin Microbiol. 1995 Dec;33(12):3133-7.

41.

Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994.

Mikhailovich VM, Melnikov VG, Mazurova IK, Wachsmuth IK, Wenger JD, Wharton M, Nakao H, Popovic T.

J Clin Microbiol. 1995 Nov;33(11):3061-3.

42.

Risk factors for group B streptococcal disease in adults.

Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD, Wenger JD, Schuchat A.

Ann Intern Med. 1995 Sep 15;123(6):415-20.

PMID:
7639440
43.

Barriers to prevention of perinatal group B streptococcal disease.

Jafari HS, Schuchat A, Hilsdon R, Whitney CG, Toomey KE, Wenger JD.

Pediatr Infect Dis J. 1995 Aug;14(8):662-7.

PMID:
8532422
44.

Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus.

Tappero JW, Perkins BA, Wenger JD, Berger TG.

Clin Microbiol Rev. 1995 Jul;8(3):440-50. Review.

45.

Should college students be vaccinated against meningococcal disease? A cost-benefit analysis.

Jackson LA, Schuchat A, Gorsky RD, Wenger JD.

Am J Public Health. 1995 Jun;85(6):843-5.

46.

Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group.

Tappero JW, Schuchat A, Deaver KA, Mascola L, Wenger JD.

JAMA. 1995 Apr 12;273(14):1118-22.

PMID:
7707600
47.

Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis.

Reeves MW, Perkins BA, Wenger JD.

Emerg Infect Dis. 1995 Apr-Jun;1(2):53-4. No abstract available.

48.

Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994.

Popovic T, Wharton M, Wenger JD, McIntyre L, Wachsmuth IK.

J Infect Dis. 1995 Apr;171(4):765-7. No abstract available.

PMID:
7706801
49.

Serogroup C meningococcal outbreaks in the United States. An emerging threat.

Jackson LA, Schuchat A, Reeves MW, Wenger JD.

JAMA. 1995 Feb 1;273(5):383-9.

PMID:
7823383
50.

Haemophilus influenzae type b disease in Latvia.

Gellert GA, Wenger JD, Brilla A.

Lancet. 1994 Oct 1;344(8927):959. No abstract available.

PMID:
7934374

Supplemental Content

Loading ...
Support Center